CT European Fund Z Accumulation GBPRegister to Unlock Ratings |
Performance History | 30/09/2024 |
Growth of 1,000 (GBP) | Advanced Graph |
Fund | 10.7 | 17.0 | -6.0 | 13.0 | 7.4 | |
+/-Cat | 1.3 | 1.6 | 2.7 | -0.6 | 1.9 | |
+/-B’mrk | 2.8 | -0.2 | 1.5 | -2.0 | 0.7 | |
Category: Europe ex-UK Equity | ||||||
Category Benchmark: Morningstar DM Eur xUK TME ... |
Key Stats | ||
NAV 11/10/2024 | GBP 3.15 | |
Day Change | 0.34% | |
Morningstar Category™ | Europe ex-UK Equity | |
IA (formerly IMA) Sector | Europe Excluding UK | |
ISIN | GB00B8C2LS47 | |
Fund Size (Mil) 30/09/2024 | GBP 783.76 | |
Share Class Size (Mil) 11/10/2024 | GBP 71.44 | |
Max Initial Charge | 3.00% | |
Ongoing Charge 31/03/2024 | 0.88% |
Investment Objective: CT European Fund Z Accumulation GBP |
The Fund aims to achieve capital growth over the long term. It looks to outperform the FTSE World Europe ex UK Index over rolling 3-year periods, after the deduction of charges. The Fund is actively managed, and invests at least 75% of its assets in shares of companies domiciled in Continental Europe, or which have significant Continental European business operations. |
Returns | |||||||||||||
|
Management | ||
Manager Name Start Date | ||
Paul Doyle 24/06/2014 | ||
Frederic Jeanmaire 01/12/2019 | ||
Inception Date 01/10/2012 |
Advertisement |
Category Benchmark | |
Fund Benchmark | Morningstar Benchmark |
FTSE World Eur Ex UK TR EUR | Morningstar DM Eur xUK TME NR EUR |
Target Market | ||||||||||||||||||||
|
Portfolio Profile for CT European Fund Z Accumulation GBP | 31/07/2024 |
|
|
Top 5 Holdings | Sector | % |
Novo Nordisk A/S Class B | Healthcare | 7.32 |
ASML Holding NV | Technology | 6.69 |
SAP SE | Technology | 5.34 |
Nestle SA | Consumer Defensive | 5.02 |
Novartis AG Registered Shares | Healthcare | 4.84 |
Increase Decrease New since last portfolio | ||
CT European Fund Z Accumulation GBP |